Identification of barriers to insulin therapy and approaches to overcoming them

Russell‐Jones, David, Pouwer, Frans, Khunti, Kamlesh·2018·Diabetes, Obesity and Metabolism
DOI 10.1111/dom.13132

Cited by (238)

Items 201–238 of 238

  1. Future of once-weekly insulins in type 2 diabetes: efficacy and safety
    Edith Wing-Kar Chow, Elaine Chow · 2025 · The Lancet
  2. Frecuencia y factores asociados a la inercia tera¬péutica en inicio de insulinización en pacientes con Diabetes Mellitus II en el Hospital José Carrasco Arteaga, Cuenca, 2018
    Andrea Estefanía Díaz Torres, Thalía Alejandra Durán Urdiales · 2021 · Revista Médica HJCA
  3. Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83)
    Tae Jung Oh · 2022 · Diabetes & Metabolism Journal
  4. A practical approach and algorithm for intensifying beyond basal insulin in type 2 diabetes
    Ronald Goldenberg, Peter Assimakopoulos, Jeremy D. Gilbert, Irving S. Gottesman, Jean‐François Yale · 2018 · Diabetes Obesity and Metabolism
  5. Advances in knowledge
    Debbie Tolson, Graham A. Jackson · 2019 · Routledge eBooks
  6. Attitudes and opinions of clinicians toward severe hypoglycemia and its management
    Mario Alberto Occhipinti · 2020 · The Journal of AMD
  7. ¿Por qué no insulinizamos cuando es necesario?
    Flora López Simarro · 2021
  8. Cuándo y cómo iniciar la insulinización
    Patxi Ezkurra Loiola · 2021
  9. FOX Algorithm Implementation: a hardware design approach.
    Colm O'keeffe, Emanuel Mihai Popovici · 2005 · IACR Cryptology ePrint Archive
  10. Insulinothérapie basale chez les patients diabétiques de type 2
    Yann Vuignier, Abdallah Roukain, Christophe Kosinski, Anne Wojtusciszyn · 2021 · JMIG
  11. Therapie des Typ-2-Diabetes
    Rüdiger Landgraf, Jens Aberle, Andreas L. Birkenfeld, Baptist Gallwitz, Monika Kellerer, Harald H. Klein, Dirk Müller‐Wieland, Michael Albrecht Nauck, Hans‐Martin Reuter, Erhard G. Siegel · 2021 · Der Diabetologe
  12. Adherence to Therapeutic Regimens in Diabetic Patients in Tertiary Care Hospitals
    Arif Mumtaz, Muhammad Ikram Shah, Ghazala Shaheen, Qaisar Ali Khan, Naseer Ahmad, Amir M Khan · 2022 · Pakistan Journal of Medical and Health Sciences
  13. Kombinasi Insulin Basal dengan GLP-1 RA dalam FRC (iGlarLixi) terhadap Pencapaian Target DM tipe 2
    Maria Cecilia Gritce Widjaja · 2022 · Jurnal Health Sains
  14. Blood glucose may be another index to initiate insulin treatment besides glycated hemoglobin A1c after oral antidiabetic medications failure for glycemic control: A real–world survey
    Yanli Li, Yan Yun Wu, Yi Shu, Shu Li, Jian‐Hao Pei, Hong Chen, Shiping Liu, Guangda Xiang, Wenbo Wang, Peng‐Fei Shan et al. · 2022 · Frontiers in Endocrinology
  15. Clinical Inertia of Discharge Planning Among Patients with Diabetes in Elhwari General Hospital
    Khaled Mahmoud, Safia Youniss, Adela H Elamami · 2022 · European Medical Journal
  16. IDF2022-0810 A nurse-driven, digital intervention for effective insulin initiation and titration in type 2 diabetes in primary care
    Patrick Ngassa Piotie, Elizabeth M. Webb, Paul Rheeder · 2023 · Diabetes Research and Clinical Practice
  17. Safety and Clinical Outcomes of Insulin Degludec in Korean Patients with Diabetes in Real-World Practices: A Prospective, Observational Study
    Byung‐Wan Lee, Kyu Jeung Ahn, Ho‐Chan Cho, Eun Young Lee, Kyung Wan Min, Amine Dahaoui, Jin Sook Jeong, Hyo Jin Lim, Hak Chul Jang · 2023 · Diabetes Therapy
  18. The Short-Term Cost-Effectiveness of a Fixed-Ratio Combination of Insulin Degludec and Aspart: A Cost of Control Analysis in Australia and India
    Jack Garcia Uranga Romano, Samuel J. P. Malkin, Barnaby Hunt · 2024 · Value in Health Regional Issues
  19. Retrospective Analysis on Efficacy and Safety of Glargine 100U and 300U in South Indian Type 2 Diabetes Population
    Ganga Kiran, Nadiminty Ganapathi Sastry, G. Kumar, S. Dilipkumar, L. Tejaswini Kalva, G. Sireesha · 2024 · International Journal of Medical Arts
  20. Weekly Insulins and Therapeutic Burden in Type 2 Diabetes
    Julie R. Ingelfinger, Clifford james Rosen · 2025 · New England Journal of Medicine
  21. Von den klinischen Studien in die Praxis – Erfahrungen mit dem Wocheninsulin Icodec
    Stefan Gölz · 2025 · Journal für Endokrinologie Diabetologie und Stoffwechsel
  22. Additional file 1 of Feasibility and acceptability of the use of flash glucose monitoring encountered by Indigenous Australians with type 2 diabetes mellitus: initial experiences from a pilot study
    Audrey Eer, Rebecca Chia Yee Ho, Tracey Hearn, Mariam Hachem, Megan Freund, Burchill, Luke James, Sharon Atkinson‐Briggs, Singh, Satpal, Sandra Eades, Richard Charles O’Brien et al. · 2024 · Figshare
  23. Additional file 1 of Physician related barriers towards insulin therapy at primary care centres in Trinidad: a cross-sectional study
    Shastri Motilal · 2020 · Figshare
  24. Barriers and facilitators to insulin management in pregnant people with gestational diabetes mellitus: A qualitative study
    Idayat M. Akinola, Kathryn E. Flynn, Lynn M. Yee, Eleanor Saffian, Zaira Peterson, Anna Palatnik · 2026 · Pregnancy
  25. Using Artificial Intelligence to optimize agreement between interstitial sensors and capillary puncture in glycemic assessment and classification
    Luana Rodrigues Ecker, Neylane Araújo Cordeiro, Camila Fernandes Caldato, Cláudio Eduardo Corrêa Teixeira · 2026 · medRxiv
  26. Impacts of insulin storage and injection techniques intervention on glycemic control among patients with diabetes in northwest Ethiopia: a quasi-experimental study
    Samuel Berihun Dagnew, Woretaw Sisay Zewdu, Samuel Agegnew Wondm, Tilaye Arega Moges, Fisseha Nigussie Dagnew, Sisay Sitotaw Anberbr, Getachew Yitayew Tarekegn, Tigabu Eskeziya Zerihun, Desalegn Addis Mussie, Abel Temeche Kassaw et al. · 2026 · Therapeutic Advances in Endocrinology and Metabolism
  27. Optimizing Diabetes Management: Insights from a Prospective Study
    Loubna Saadaoui, Fatima Zahrae Melki, Hayat Aynaou, Houda Salhi · 2026 · Case Reports in Clinical Medicine
  28. Saudi family physician’s clinical inertia of type 2 diabetes management
    Abdulaziz F. Alfadhly, Rawan Naif Althomali, Abdulelah Ahmed Asiri, Saud Khalaf Alhothaly, Faisal Musaad Alhoshan, Afnan Almajnouni, Basim Matar Almalki, Saad M. Alfaez, Raghad Faisal Alharthi, Abdullah Ahmed Amalki et al. · 2026 · Journal of Family Medicine and Primary Care
  29. Efficacy and safety of switching to iGlarLixi from premixed insulin therapy in patients with type 2 diabetes: A real‐world experience
    Chun‐Jui Huang, S N Yang, Cheng-Pin Cheng, Chun‐Hsing Lin, Y. S. Lee, Harn-Shen Chen · 2026 · Diabetic Medicine
  30. Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: Results from a Japanese cohort study (JDDM53).
    聡 前川, Hiroshi Maegawa, Yasushi Ishigaki, Jakob LANGER, Ai Saotome‐Nakamura, Marc Andersen, Japan Diabetes Clinical Data Management (JDDM) Study Group · 2020 · Institutional Repositories DataBase (IRDB)
  31. Therapeutic Inertia in Chronic Disease Management
    Ikram Mustapha Zoukh, Ahmed Awaisu, Yaw Owusu, Muhammad Abdul Hadi, Zeinab Dabbous · 2026 · Elsevier eBooks
  32. Experiences of People with Type 2 Diabetes and Healthcare Professionals with Once-Weekly Insulin Efsitora Alfa in QWINT Phase 3 Trials: Qualitative In-Trial Interviews
    William H. Polonsky, Emma Low, Carla Dias-Barbosa, Amy Clark, Karen Bailey, Liza Ilag, LIVIA FIRMINO GONCALVES, Rebecca J. Threlkeld, Christopher J. Child, Michael B. Davidson et al. · 2026 · Patient
  33. Pharmacokinetics, Pharmacodynamics, and Safety of Once-Weekly Insulin Efsitora Alfa in Chinese Patients with Type 2 Diabetes: A Phase 1 Open-Label, Randomized, Active-Controlled Trial
    H L Liu, Yuxin Fan, Y C Wang, Yuan Yuan, Jennifer K. Leohr, Ming Liu, Yerong Yu · 2026 · Advances in Therapy
  34. Once-weekly insulins: a paradigm shift in the management of type 2 diabetes?
    Kimia Saleh Anaraki, Kashif M. Munir, Stephen N. Davis · 2026 · Expert Opinion on Pharmacotherapy
  35. Tip 2 Diyabetli Yetişkinlerin Psikolojik İnsülin Direnci: Kesitsel Çalışma
    Vahide Semerci Çakmak, Ebru Sönmez Sarı, Zahide Akeren, Servet Kalyoncuo · 2026 · Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi
  36. Insulin initiation and titration for people with type 2 diabetes managed in primary care and guided by continuous glucose monitoring
    Ramzi Ajjan, Tadej Battelino, Xavier Cos, Stefano Del Prato, Chantal Mathieu, Mohammed S. Almehthel, Jochen Seufert, Bruno Guerci, Samuel Seidu · 2026 · The Lancet Primary Care
  37. Insulin Prescribing Challenges and Physician‐Suggested Interventions: Evidence From a Tertiary Care Hospital in Lahore, Pakistan
    Muhammad Salman Aamir, Bazila Nafeesa, Adeel Aslam, Asma Ghulam Mustafa, Mateen Elahi, Amin Elahi, Kashif Barkat, Muhammad Umer Ashraf, Mohd Shahezwan Abd Wahab, Sumera Saeed Akhtar · 2026 · Endocrinology Diabetes & Metabolism
  38. Patient‐Reported Outcomes Following Initiation or Simplification of Treatment With iGlarLixi in Adults With Type 2 Diabetes: A Narrative Review
    Francesco Giorgino, Martin Haluzı́k, Agustina Alvarez, Felipe Lauand, Samir Helmy Assaad-Khalil, Hemant P Thacker, Tomasz Klupa, Oğuzhan Deyneli, Julio Rosenstock · 2026 · Diabetes Obesity and Metabolism